Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

China Medical System’s Novel Nasal Spray Approved to Treat Seizures in China

publication date: Jun 13, 2023

China Medical System Holdings was approved to launch its novel Diazepam Nasal Spray in China to treat seizure clusters in epilepsy patients who are at least 6 years old. Although diazepam is commonly prescribed for epilepsy globally, there are no China-approved diazepam products for the condition. CMS’s novel nasal delivery system allows easy administration with a fast onset of just four minutes to stop seizures. In a US trial, 87% of seizure cluster episodes required only a single dose of the product over a 24-hour period. More details....

Stock Symbol: (HK: 0867)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital